These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
985 related articles for article (PubMed ID: 30003451)
1. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues. Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451 [TBL] [Abstract][Full Text] [Related]
2. Establishment of Patient-Derived Gastric Cancer Organoid Model From Tissue Obtained by Endoscopic Biopsies. Song H; Park JY; Kim JH; Shin TS; Hong SA; Huda MN; Kim BJ; Kim JG J Korean Med Sci; 2022 Jul; 37(28):e220. PubMed ID: 35851862 [TBL] [Abstract][Full Text] [Related]
3. Development of a Single-Cell Technique to Increase Yield and Use of Gastrointestinal Cancer Organoids for Personalized Medicine Application. Gao M; Harper MM; Lin M; Qasem SA; Patel RA; Mardini SH; Gabr MM; Cavnar MJ; Pandalai PK; Kim J J Am Coll Surg; 2021 Apr; 232(4):504-514. PubMed ID: 33253861 [TBL] [Abstract][Full Text] [Related]
4. Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer. Zhao Y; Li S; Zhu L; Huang M; Xie Y; Song X; Chen Z; Lau HC; Sung JJ; Xu L; Yu J; Li X Cell Rep Med; 2024 Jul; 5(7):101627. PubMed ID: 38964315 [TBL] [Abstract][Full Text] [Related]
5. Patient-derived organoid culture of gastric cancer for disease modeling and drug sensitivity testing. Zu M; Hao X; Ning J; Zhou X; Gong Y; Lang Y; Xu W; Zhang J; Ding S Biomed Pharmacother; 2023 Jul; 163():114751. PubMed ID: 37105073 [TBL] [Abstract][Full Text] [Related]
6. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine. Pamarthy S; Sabaawy HE Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953 [TBL] [Abstract][Full Text] [Related]
7. Patient-Derived Organoids from Locally Advanced Gastric Adenocarcinomas Can Predict Resistance to Neoadjuvant Chemotherapy. Yoon C; Lu J; Kim BJ; Cho SJ; Kim JH; Moy RH; Ryeom SW; Yoon SS J Gastrointest Surg; 2023 Apr; 27(4):666-676. PubMed ID: 36627466 [TBL] [Abstract][Full Text] [Related]
8. Implementing cell-free DNA of pancreatic cancer patient-derived organoids for personalized oncology. Dantes Z; Yen HY; Pfarr N; Winter C; Steiger K; Muckenhuber A; Hennig A; Lange S; Engleitner T; Öllinger R; Maresch R; Orben F; Heid I; Kaissis G; Shi K; Topping G; Stögbauer F; Wirth M; Peschke K; Papargyriou A; Rezaee-Oghazi M; Feldmann K; Schäfer AP; Ranjan R; Lubeseder-Martellato C; Stange DE; Welsch T; Martignoni M; Ceyhan GO; Friess H; Herner A; Liotta L; Treiber M; von Figura G; Abdelhafez M; Klare P; Schlag C; Algül H; Siveke J; Braren R; Weirich G; Weichert W; Saur D; Rad R; Schmid RM; Schneider G; Reichert M JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32614802 [TBL] [Abstract][Full Text] [Related]
9. In vitro drug testing using patient-derived ovarian cancer organoids. Chen LY; Chou YT; Liew PL; Chu LH; Wen KC; Lin SF; Weng YC; Wang HC; Su PH; Lai HC J Ovarian Res; 2024 Oct; 17(1):194. PubMed ID: 39358778 [TBL] [Abstract][Full Text] [Related]
10. Creation of EGD-Derived Gastric Cancer Organoids to Predict Treatment Responses. McDonald HG; Harper MM; Hill K; Gao A; Solomon AL; Bailey CJ; Lin M; Barry-Hundeyin M; Cavnar MJ; Mardini SH; Pandalai PJ; Patel RA; Kolesar JM; Rueckert JA; Hookey L; Ropeleski M; Merchant SJ; Kim J; Gao M Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37296998 [TBL] [Abstract][Full Text] [Related]
11. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients. Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046 [TBL] [Abstract][Full Text] [Related]
12. Gastric cancer patient-derived organoids model for the therapeutic drug screening. Xu J; Gong J; Li M; Kang Y; Ma J; Wang X; Liang X; Qi X; Yu B; Yang J Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130566. PubMed ID: 38244703 [TBL] [Abstract][Full Text] [Related]
13. Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening. Li J; Xu H; Zhang L; Song L; Feng D; Peng X; Wu M; Zou Y; Wang B; Zhan L; Hua G; Zhan X J Cancer Res Clin Oncol; 2019 Nov; 145(11):2637-2647. PubMed ID: 31598791 [TBL] [Abstract][Full Text] [Related]
14. Precision Medicine in Pancreatic Cancer: Patient-Derived Organoid Pharmacotyping Is a Predictive Biomarker of Clinical Treatment Response. Seppälä TT; Zimmerman JW; Suri R; Zlomke H; Ivey GD; Szabolcs A; Shubert CR; Cameron JL; Burns WR; Lafaro KJ; He J; Wolfgang CL; Zou YS; Zheng L; Tuveson DA; Eshlemann JR; Ryan DP; Kimmelman AC; Hong TS; Ting DT; Jaffee EM; Burkhart RA Clin Cancer Res; 2022 Aug; 28(15):3296-3307. PubMed ID: 35363262 [TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response. Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029 [TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of luteolin proven by patient-derived organoids of gastric cancer. Hao X; Zu M; Ning J; Zhou X; Gong Y; Han X; Meng Q; Li D; Ding S Phytother Res; 2023 Nov; 37(11):5315-5327. PubMed ID: 37469042 [TBL] [Abstract][Full Text] [Related]
17. Patient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug Responses. de Witte CJ; Espejo Valle-Inclan J; Hami N; Lõhmussaar K; Kopper O; Vreuls CPH; Jonges GN; van Diest P; Nguyen L; Clevers H; Kloosterman WP; Cuppen E; Snippert HJG; Zweemer RP; Witteveen PO; Stelloo E Cell Rep; 2020 Jun; 31(11):107762. PubMed ID: 32553164 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues. Tamura H; Higa A; Hoshi H; Hiyama G; Takahashi N; Ryufuku M; Morisawa G; Yanagisawa Y; Ito E; Imai JI; Dobashi Y; Katahira K; Soeda S; Watanabe T; Fujimori K; Watanabe S; Takagi M Oncol Rep; 2018 Aug; 40(2):635-646. PubMed ID: 29917168 [TBL] [Abstract][Full Text] [Related]